AI & RoboticsNews

Researchers detail TrojAI, a framework for hardening AI models against adversarial attacks

One way to test machine learning models for robustness is with what’s called a trojan attack, which involves modifying a model to respond to input triggers that cause it to infer an incorrect response. In an attempt to make these tests more repeatable and scalable, researchers at Johns Hopkins University developed a framework dubbed TrojAI, a set of tools that generate triggered data sets and…
Read more
AI & RoboticsNews

Nvidia researchers use AI to teach robots how to hand objects to humans

In a preprint research paper published this week, Nvidia researchers propose an approach for human-to-robot handovers in which the robot meets the human halfway, classifies the human’s grasp, and plans a trajectory to take the object from the human’s hand. They claim it results in more fluent handovers compared with baselines, and they say it could inform the design of collaborative warehouse…
Read more
AI & RoboticsNews

The emergence of the professional AI risk manager

When the 1970s and 1980s were colored by banking crises, regulators from around the world banded together to set international standards on how to manage financial risk. Those standards, now known as the Basel standards, define a common framework and taxonomy on how risk…
AI & RoboticsNews

AI Weekly: Coronavirus spurs adoption of AI-powered candidate recruitment and screening tools

As COVID-19 continues to spread — as of the time of writing (March 12), there were over 139,600 confirmed cases and over 5,100 deaths — companies are increasingly adopting alternatives to in-person job interviews and talent recruitment. Recruiters PageGroup and Robert Walters have announced plans to move some job interviews and interactions online, following on the heels of tech giants Amazon…
Read more
AI & RoboticsNews

Vida Diagnostics raises $11 million to diagnose lung diseases with AI

Vida Diagnostics, a provider of AI-powered lung imaging analysis tools, today announced that it’s raised $11 million. CEO Susan A. Woods said the funds will be used to accelerate the commercialization and expansion of the company’s product portfolio, which she says could address market deficits in the early assessment, monitoring, and treatment of lung disease. “We are driven to continuously…
Read more